EUCROFT Conference, Brussels

October 2013

Janet will be speaking at the session on Low Risk Studies: The legal difficutlies in taking advantage of the Cchanges.

The session will look at the specific changes in the new regulation and the relaxation of requirements under it to consider:

• how far an interventional clinical trial which is currently regulated may no longer be so, is it clear what are "low-intervention" clinical trials,
• which low-intervention clinical trials fall outside the definition,
• how far the regulation gives consistency across the EU, 
• liability issues despite the relaxations.

For more information on the conference please follow the link: http://www.eucrof-conference.eu/home/